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Abstract
Introduction The majority of autoimmune diseases such as
rheumatoid arthritis (RA) and autoimmune thyroid diseases
(AITDs) are characterized by a striking female predominance
superimposed on a predisposing genetic background. The role
of extremely skewed X-chromosome inactivation (XCI) has been
questioned in the pathogenesis of several autoimmune
diseases.
Methods We examined XCI profiles of females affected with RA
(n = 106), AITDs (n = 145) and age-matched healthy women (n
= 257). XCI analysis was performed by enzymatic digestion of
DNA with a methylation sensitive enzyme (HpaII) followed by
PCR of a polymorphic CAG repeat in the androgen receptor
(AR) gene. The XCI pattern was classified as skewed when
80% or more of the cells preferentially inactivated the same X-
chromosome.
Results Skewed XCI was observed in 26 of the 76 informative
RA patients (34.2%), 26 of the 100 informative AITDs patients
(26%), and 19 of the 170 informative controls (11.2%) (P <
0.0001; P = 0.0015, respectively). More importantly, extremely
skewed XCI, defined as > 90% inactivation of one allele, was
present in 17 RA patients (22.4%), 14 AITDs patients (14.0%),
and in only seven controls (4.1%, P < 0.0001; P = 0.0034,
respectively). Stratifying RA patients according to laboratory
profiles (rheumatoid factor and anti-citrullinated protein
antibodies), clinical manifestations (erosive disease and
nodules) and the presence of others autoimmune diseases did
not reveal any statistical significance (P > 0.05).
Conclusions These results suggest a possible role for XCI
mosaicism in the pathogenesis of RA and AITDs and may in part
explain the female preponderance of these diseases.
Introduction
It is postulated that the paternal and maternal antigens will be
recognized by the immune system within the thymus, and T
cells that have a high affinity for such antigens will be deleted
by apoptosis [1-3]. The lack of exposure to a self-antigen in the
thymus may lead to the presence of autoreactive T cells and
increase the risk of autoimmunity [4]. In female mammalian
cells, one of the two X-chromosomes is inactivated in early
embryonic life [5]. Thus, females are mosaics for two cell pop-
ulations, cells with either the paternal or the maternal X in the
active form. X-chromosome choice is assumed to be random,
and the result is generally 50% of cells expressing the paternal
and the remaining 50% expressing the maternal genes [6]. A
skewed X-chromosome inactivation (XCI) is a deviation from
this ratio and is arbitrarily defined, for example, as a pattern
where 80% or more of the cells inactivate the same X-chromo-
some [7]. This deviation may be the result of chance or genetic
factors involved in the XCI or a selection process [8]. ThePage 1 of 8
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where by X-linked self-antigens may escape presentation in
the thymus or in other peripheral sites that are involved in tol-
erance induction [9,10]. This has become an attractive candi-
date mechanism for breakdown of self-tolerance in
autoimmune diseases. An association between skewed XCI
and scleroderma was recently reported [11]. A higher fre-
quency of a skewed XCI pattern was found in patients affected
with autoimmune thyroid diseases (AITDs) compared with
healthy controls, indicating that skewed XCI may be associ-
ated with a predisposing factor for the development of AITDs
[12-14]. It was therefore of interest to study if there is an asso-
ciation between skewed XCI and rheumatoid arthritis (RA) as
a non-organ-specific and AITDs as an organ-specific autoim-
mune disease. We investigated the peripheral blood XCI pat-
terns of 106 females affected with RA, 145 females affected
with AITDs and 257 controls in the Tunisian and Turkish pop-
ulations. Extremely skewed XCI was found in the blood sam-
ples of female patients affected with RA and AITDs supporting





One hundred and six Tunisian women affected with RA were
recruited into the study. All patients fulfilled the 1987 Ameri-
can College of Rheumatology criteria for RA [15]. A rheuma-
tologist university fellow (ZB) reviewed all clinical data. The
mean age was 47.6 ± 13.4 (mean ± standard deviation (SD))
years. The duration of the symptoms was 15 ± 8.9 years. The
mean age of diagnostic was 40.3 ± 12 years. Among 106 RA
patients, 65 were rheumatoid factor (RF) positive (61.3%), 70
were anti-citrullinated protein/peptide antibodies (ACPA) pos-
itive (66%), 15 presented with nodules (14.1%), and 70 pre-
sented with erosive disease (66%). Fifteen patients had
another accompanying autoimmune diseases such as Sjö-
gren's syndrome, type 1 diabetes, or autoimmune thyroid dis-
eases.
AITDs sample
One hundred and forty-five Tunisian women affected with
AITDs were included in the study. There were a total of 58
patients with Graves' disease (GD) and 87 patients with
Hashimoto's thyroiditis (HT), which include 40 patients with
the goitrous form. The mean age was 46.5 ± 14.5 years for
AITDs patients (49.3 ± 13 years in HT patients and 44.6 ± 14
years in GD patients). The duration of the symptoms was 7.5
± 4.6 years among the AITDs patients (6.8 ± 4.8 years in HT
patients and 7.2 ± 4 years in GD patients). The mean age of
diagnosis was 37.9 ± 15.1 years. The diagnosis of GD was
based on the presence of biochemical hyperthyroidism as indi-
cated by a decrease of thyroid-stimulating hormone (TSH), an
increase of T4 levels, and positive TSH receptor antibody, in
association with diffuse goiter or the presence of exophthal-
mos. The diagnosis of HT was based on the presence of thy-
roid hormone replaced primary hypothyroidism, defined as a
TSH level above the upper limits associated with positive titers
of thyroid autoantibodies (anti-thyroglobulin and/or anti-thyroid
peroxidase) and with or without a palpable goiter.
Control group
Caucasian females, comprised of 97 Tunisian and 160 Turkish
healthy unrelated volunteers, served as controls in our studies.
The mean (± SD) age at analysis was 43.5 ± 15.3 years and
35 ± 9.9 years for Tunisian and Turkish controls, respectively.
There was no clinical evidence or family history of autoimmune
disease and inflammatory joint disease.
All individuals (patients and controls) provided informed con-
sent. The ethics committee of the Centre Hospitalo-Universi-
taire Hédi Chaker de Sfax, Tunisie, and the Bilkent University,
Ankara, Turkey approved the study protocol.
Methods
Autoantibodies analysis
In AITDs patients, thyroid autoantibodies (anti-thyroglobulin
and anti-thyroid peroxydase) were measured by ELISA and
indirect immunofluorescence using commercially available kits
Table 1
Proportion of RA and AITDs patients and controls with skewed X-chromosome inactivation
Number (%) observed with skewed
Degree of skewing (%) RA (n = 76) AITDs (n = 100) Control females (n = 170)
90+ 17 (22.4) 14 (14) 7 (4.1)
80 to 89 9 (11.8) 12 (12) 12 (7.1)
70 to 79 11 (14.5) 23 (23) 29 (17.1)
60 to 69 28 (36.8) 22 (22) 36 (21.2)
50 to 59 11 (14.5) 29 (29) 86 (50.6)
For comparison by chi-squared P < 0.0001 and P = 0.0015 (> 80% skewing); P < 0.0001 and P = 0.0034 (90+% skewing) for patients with 
rheumatoid arthritis (RA) and autoimmune thyroid diseases (AITDs), respectively.Page 2 of 8
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UK) with the respective normal ranges of 0 to 100 and 0 to 70
IU/mL.
The sera of RA patients obtained at the time of diagnosis were
examined for RF by nephelometry and for ACPA by ELISA
(second-generation test; Euro-Diagnostica, Arnhem, the Neth-
erlands).
X-chromosome inactivation study
Genomic DNA was extracted from 10 ml of peripheral blood
lymphocyte of patients and controls using standard methods
[16]. Genotyping of a polymorphic site in the androgen recep-
tor (AR) gene was performed and quantified to assess the XCI
patterns as described [17]. The degree of skewing was esti-
mated by an assay based on a methylation-sensitive HpaII
restriction site located in exon 1 of the AR gene. This site is
methylated on the inactive X, and unmethylated on the active
X-chromosome. When the genomic DNA is cleaved with HpaII
prior to PCR, only the methylated AR allele, which represents
the inactive X-chromosome, is amplified. A polymorphic CAG
repeat located within the amplified region is used to distin-
guish between the two alleles. For each patient and control
two separate PCRs, with or without HpaII treatment, were per-
formed using the same set of primers. Densitometric analysis
of the alleles was performed at least twice for each sample
using the MultiAnalyst version 1.1 software (Bio-rad, Hercules,
California, USA). A corrected ratio (CrR) was calculated by
dividing the ratio of the predigested sample (upper/lower
allele) by the ratio of the non-predigested sample for normali-
zation of the ratios that were obtained from the densitometric
analyses. The use of CrR compensates for preferential ampli-
fication of the shorter allele when the number of PCR cycles
increases [18]. A skewed population is defined as a cell pop-
ulation with greater than 80% expression of one of the AR alle-
les. This corresponds to CrR values of less than 0.33 or more
than three.
Statistical methods
The results from control and test groups in XCI studies were
compared by chi-squared test with Yate's correction. Fisher's
exact test was used when one cell had an expected count of
Figure 1
Distribution of X-chromosome inactivation patterns according to age in patients with rheumatoid arthritis.
Figure 2
Distribution of X-chromosome inactivation patterns according to age in patients with autoimmune thyroid diseases.Page 3 of 8
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count of less than five. P values of 0.05 or less were consider-
ate to be significant. Significance of P value was assessed
using a Bonferroni correction at 5% (a P value less 0.05/9 =
0.005) is considered significant.
Results
XCI status was found to be informative in 76 of the 106 RA
patients, 100 of the 145 AITDs patients and 170 of the 257
controls. Only those individuals whose alleles resolve ade-
quately for densitometric analysis were included in the study.
Skewed XCI (> 80% skewing) was observed in 26 of the 76
RA patients (34.2%), 26 of the 100 AITDs patients (26%), and
19 of the 170 controls (11.2%; P < 0.0001 and P = 0.0015).
More importantly, the frequency of extremely skewed XCI (>
90% skewing) was 22.4% (17 of 76) in RA and 14.0% (14 of
100) in AITDs. These frequencies are both significantly higher
than that of the control population, which is 4.1% (7 of 170; P
< 0.0001 and P = 0.0034; Table 1). Subdividing AITDs
patients according to clinical phenotype revealed that the fre-
quency of skewed XCI was 35% (14 of 40, P = 0.0001) and
20% (12 of 60, P = 0.04) in GD and HT, respectively. Con-
versely, stratifying RA patients according to RF status, ACPA
status, clinical manifestations (erosive disease and nodules)
and others autoimmune diseases did not reveal a statistically
significant difference (P > 0.05). Additionally, the comparison
according to geographic origin showed a skewed XCI of RA
patients compared with Tunisian controls (34.2% versus
19.5%; P = 0.03). However, difference was non-significant for
AITDs subgroup (P > 0.05).
Extremely skewed XCI have been reported in 1 to 2% of 20 to
40 year old women, and in 2 to 4% of 55 to 72 year old women
[19]. The data for RA and AITDs patients is strikingly bimodal,
we plotted the distribution of the X inactivation profiles accord-
ing to age. However, we did not observe a shift toward the
skewed range in older patients and controls (Figures 1, 2 and
3). Characteristics of the RA and AITDs patients with skewed
XCI are shown in Tables 2 and 3.
At the time of sample collection, 66 patients affected with RA
were being treated with immunosuppressive therapies (meth-
otrexate 10 to 15 mg once a week, n = 33; D-penicillamine
300 mg/day, n = 17; plaquenil 400 to 600 mg/day, n = 16).
Among 76 informative patients, 46 were received immunosup-
pressive agents (61%). A major concern with the observed
XCI patterns among RA patients was that concomitant immu-
nosuppressive therapy could influence the results, as has
been observed in feline hematopoietic cells [20]. Analysis of
the data on XCI patterns according to immunosuppressive
therapy did not reveal a statistically significant association
between RA patients treated with methotrexate and controls
(P = 0.52).
Discussion
The majority of human autoimmune diseases are characterized
by female predominance. RA and AITDs have a female:male
ratio of approximately 3:1 and 9:1, respectively [21]. Sex hor-
mone influences have been suggested to explain this phenom-
enon because the X-chromosome contains a considerable
number of sex and immune-related genes such as AR, IL2
receptor gamma chain, CD40 ligand and FOXP3 [22,23].
These genes are essential in determining sex hormone levels
and, more importantly, immune tolerance [24]. The contribu-
tion of genetics to sex differences in autoimmune diseases is
currently unexplored. An alternative explanation for the female
predominance has been recently proposed with the finding of
an enhanced skewed XCI in peripheral bloods cells of female
patients with autoimmune diseases [11-14]. The present
study tests the hypothesis that skewed XCI would be more
prevalent in females affected with autoimmune diseases than
in female control individuals. Therefore, we simultaneously
examined skewed XCI in 106 patients affected with RA and
145 patients affected with AITDs. The control group consisted
Figure 3
Distribution of X-chromosome inactivation patterns according to age control subjects. The control subjects were plotted according to geographic 
origin. Gray diamonds represent Tunisian controls and black diamonds represent Turkish controls.Page 4 of 8
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onstrated a significantly higher prevalence of extremely
skewed XCI in blood cell of females affected with RA and
AITDs compared with the control group (P < 0.0001; P =
0.0015, respectively), indicating a possible role of XCI in the
etiology of autoimmune diseases, and in the female prepon-
derance of RA and AITDs.
Skewed XCI was more commonly expected in peripheral
blood mononuclear cells due to the very high rate of turnover
of blood cells compared with other solid tissues [25]. Then,
we have examined XCI in peripheral blood mononuclear cells
of patients affected with RA and AITDs, and we found a higher
incidence of skewed XCI in those patients. We also tested the
relationship between XCI and AITDs phenotypes (GD and
HT). A skewed XCI was associated with both GD and HT (P
= 0.0001 and P = 0.04). Although, our results suggest the
involvement of XCI in female predisposition to RA and AITDs,
this hypothesis still to be confirmed in specific tissue, because
our analysis was performed in DNA from blood, and this may
Table 2
Characteristics of the patients with rheumatoid arthritis and skewed X-chromosome inactivation





1 1949 48 G7, P4, A3 + + GSG MXT
2 1954 42 G5, P4, A1 + + - Plaquenil
3 1945 52 G7, P7, A0 - - GSG -
4 1946 40 G3, P2, A1 + - - -
5 1956 30 G2, P2, A0 - - - -
6 1946 40 G3, P2, A1 - + GSG -
7 1945 40 G4, P4, A0 + - - -
8 1945 39 G5, P5, A0 - + - -
9 1941 49 G7, P5, A2 + + - MXT
10 1947 49 G4, P3, A1 + - GSG -
11 1945 58 G4, P2, A1 - + GSG MXT
12 1950 40 G3, P2, A1 + + GSG MXT
13 1943 53 G3, P3, A0 + - - -
14 1961 35 G2, P1, A1 + - - -
15 1937 38 G4, P4, A0 - - - -
16 1941 45 G5, P3, A1 + + - -
17 1947 43 G3, P2, A0 - + GSG -
80 to 89% skewing
18 1959 42 G5, P5, A0 + + - MXT
19 1940 62 G0, P0, A0 - - - -
20 1938 60 G9, P8, A1 + + GSG MXT
21 1954 27 G0, P0, A0 + + GSG -
22 1957 37 G5, P5, A0 + + GSG -
23 1948 55 G9, P7, A0 + - - MXT
24 1948 55 G0, P0, A0 - - - -
25 1937 50 G3, P2, A1 - + GSG -
26 1985 14 G0, P0, A0 + - - -
A = spontaneous abortions; ACPA = anti-citrullinated protein/peptide antibodies; G = number of pregnancies; GSG = Sjögren's syndrome; MTX 
= methotrexate; P = para (pregnancies carried to term and delivered); RF = rheumatoid factor.Page 5 of 8
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[26,27] and there may exist locally skewed XCI in the thymus.
Moreover, this study can be complicated by existing differ-
ences in peripheral blood mononuclear cells constituents in
RA versus healthy controls. The XCI distribution in both Tuni-
sian and Turkish controls (Figure 3) according to age showed
that 19.5% (9 of 46) have a skewed XCI in Tunisian controls
which have a mean age of 43.5 years, whereas only 8% (10 of
124) in Turkish controls with a younger mean age (35 years).
This result suggests the importance of age in the difference of
XCI skewing.
Our results are in agreement with those reported by Ozçelik
and colleagues on 110 unrelated Turkish female AITDs
patients and 160 female controls that showed a greater pro-
portion of a skewed pattern of XCI (34%) than in controls (8%;
P < 0.0001) [13]. Indeed, supporting data have been reported
by Brix and colleagues, which assessed that the prevalence of
skewed XCI in female twins affected with AITDs was 34% but
Table 3
Characteristics of the patients with autoimmune thyroid diseases and skewed X-chromosome inactivation
Patient Birth date Disease onset Pregnancy history Diagnostic Auto antibodies
90+% skewing
1 1978 22 G1, P1, A0 HT +
2 1933 65 G11, P5, A0 HT +
3 1969 20 G1, P1, A1 HT +
4 1938 60 G3, P3, A0 GD +
5 1943 45 G2, P2, A0 GD +
6 1972 21 G2, P2, A0 HT +
7 1964 36 G2, P2, A0 HT +
8 1924 65 G9, P9, A0 HT +
9 1940 59 G10, P10, A0 HT +
10 1969 28 G4, P4, A0 GD +
11 1979 20 G0, P0, A0 GD -
12 1931 68 G13, P13, A0 HT -
13 1943 59 G1, P1, A0 GD -
14 1946 42 G2, P2, A0 GD -
80 to 89% skewing
15 1969 23 G2, P2, A0 HT +
16 1950 41 G3, P2, A1 GD +
17 1980 20 G0, P0, A0 HT +
18 1945 54 G4, P3, A0 HT +
19 1962 36 G7, P2, A5 HT +
20 1954 48 G3, P3, A0 GD +
21 1984 20 G0, P0, A0 GD +
22 1952 45 G2, P2, A0 GD -
23 1941 58 G5, P5, A0 HT -
24 1953 39 G2, P2, A0 GD -
25 1947 48 G1, P1, A0 HT -
26 1969 43 G2, P1, A1 GD -
A = spontaneous abortions; G = number of pregnancies; GD = Graves' disease; HT = Hashimoto's thyroiditis; P = para (pregnancies carried to 
term and delivered).Page 6 of 8
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(P = 0.004) [12-14]. Similar positive result was described in
other autoimmune diseases such as scleroderma [11]. In addi-
tion, our results are the first report that describes a significant
association between extremely skewed XCI and RA. Con-
versely, examination of XCI pattern of 58 Caucasian female
patients affected with multiple sclerosis, 46 with systemic
lupus erythematosus, 18 with juvenile RA and 45 with type 1
diabetes mellitus and 30 healthy women did not reveal skewed
XCI patterns [28]. Despite extensive efforts of XCI analysis in
different autoimmune diseases and populations, this hypothe-
sis remains to be confirmed because there is no apparent
autoimmunity directed against protein antigens encoded on
the X chromosome and the fact that, for many autoimmune dis-
eases, we found a female predominance in inbred mice mod-
els having two identical X chromosomes and therefore no
'foreign' antigens from the XCI [29].
In humans, it was reported that XCI process was genetically
controlled by genes located on X chromosome [30]. It has also
been suggested that genes on the X chromosome might show
linkage with AITD and RA [31,32]. Thus, the observed associ-
ation between skewed XCI and AITD and RA is not causal but
could be explained by linkage disequilibrium between mutation
responsible for XCI process and AITD and RA susceptibility
polymorphisms. In addition, numerous environmental risk fac-
tors such as tobacco smoking, hormones, diet, drugs, toxins
and/or infections are important in determining whether an indi-
vidual will develop autoimmune diseases [33]. In fact, environ-
mental agents are able to amplify autoimmunity in genetically
susceptible individuals and to break tolerance in genetically
resistant individuals, there by increasing the risk of developing
autoimmune diseases [34]. The interaction between genetic
and environmental factors remains to be achieved in order to
evaluate the involvement of each component in the develop-
ment of such autoimmune reactions.
Conclusions
We suggest a possible role of XCI mosaicism in the pathogen-
esis of RA and AITDs. However, the process of XCI needs to
be considered as a potential factor in the predominance of
females in most autoimmune diseases. It would also be of
interest first to study the XCI pattern in females affected with
other autoimmune diseases and second to test the XCI pat-
terns of many cell types.
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